Company news
Madrigal Pharmaceuticals, Inc. news in 2021
Madrigal Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.
Madrigal Provides Update on Timeline for Topline Results from the Phase 3 MAESTRO-NAFLD-1 Clinical Trial of Resmetirom
December 29, 2021
Madrigal Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences
November 22, 2021
Positive Resmetirom Data from Completed Open-Label Portion of Phase 3 MAESTRO-NAFLD-1 Clinical Study Presented at American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® Digital Experience 2021
November 11, 2021
Madrigal Pharmaceuticals Provides Corporate Update and Reports 2021 Third Quarter Financial Results
November 3, 2021
Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation’s Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)
October 3, 2021
Madrigal Pharmaceuticals Reports 2021 Second Quarter Financial Results and Provides Corporate Update
August 4, 2021
Robert Waltermire Joins Madrigal Pharmaceuticals as Chief Pharmaceutical Development Officer
August 1, 2021
Madrigal Pharmaceuticals Offers Patients Resmetirom in a Planned Open Label Active Treatment Extension of the Phase 3 MAESTRO-NAFLD-1 Clinical Study
July 12, 2021
Madrigal Pharmaceuticals Completes Enrollment of the 52 Week Liver Biopsy Patient Population in the Phase 3 MAESTRO-NASH Study of Resmetirom
June 29, 2021
Madrigal Pharmaceuticals Announces Presentation of Positive Clinical Data of Resmetirom from Open-Label Portion of Ongoing Phase 3 Clinical Trial MAESTRO-NAFLD-1 at The International Liver Congress™ 2021
June 24, 2021
Madrigal Pharmaceuticals to Participate in UBS Global Healthcare Virtual Conference
May 20, 2021
Madrigal Pharmaceuticals to Present at RBC Capital Markets Virtual 2021 Global Healthcare Conference on Wednesday, May 19, 2021 at 8: 00 a.m. ET
May 17, 2021
Alex Howarth Joins Madrigal Pharmaceuticals as Chief Financial Officer
May 17, 2021
Madrigal Pharmaceuticals Reports 2021 First Quarter Financial Results and Highlights
May 5, 2021
Madrigal Pharmaceuticals Reports 2020 Fourth Quarter and Full Year Financial Results and Highlights
February 24, 2021